PriceSmart (NASDAQ: PSMT) is accelerating growth and outpacing peers in revenue growth, suggesting further upside for its stock price. The risk is its valuation, which, at approximately 36x the current year forecast, is high. The caveat for bears is that this valuation aligns with peers, pricing in....
Good MorningU.S. stocks finished higher Thursday, with the Nasdaq posting a sharp gain as investors looked past escalating U.S.-Iran tensions and returned to AI-related names. The central tension was AI spend vs profitability, as buyers moved back into data center exposure while still questioning margin durability.
Market leadership remained mixed to start the second half, with reports pointing to rotation out of some of the year’s winners and into laggards, including energy. Geopolitical risks supported crude prices and kept oil and gas names in focus, giving investors a hedge against inflation pressure while AI leadership regained footing.
Semiconductor and storage stocks rebounded after reports that China may ease restrictions on advanced NVIDIA AI chip imports, lifting names tied to chip equipment, memory and data center demand. Housing data showed wealthier buyers still powering the market despite affordability concerns. Delta Air Lines' options implied a sizable move before its Friday report, putting guidance in focus. Costco fell after a June sales update, even as Bank of America stayed bullish, while Salesforce slipped after downgrades tied to weak Agentforce feedback. Traders are watching earnings for confirmation that demand can support margins. Featured: Profit on IPO day without owning a share? (Ad) 
|
Retail/Wholesale |
|
PriceSmart (NASDAQ: PSMT) is accelerating growth and outpacing peers in revenue growth, suggesting further upside for its stock price. The risk is its valuation, which, at approximately 36x the current year forecast, is high. The caveat for bears is that this valuation aligns with peers, pricing in... Read the Full Story |
|
From Our Partners |
|
Porter Stansberry spent 30 years ignoring outside investment systems - until he met Emmet Savage in Dublin. Savage's model, built on Hamiltonian mechanics applied to equity analysis, has delivered nearly 2,000% returns over 17 years with only one losing year.
What convinced Porter wasn't the returns. It was the sell discipline - a framework that identifies the exact moment a position's energy begins to decay, signaling an exit before the decline. He calls it the most rigorous sell system he has ever seen, comparing its edge to RenTech's famed Medallion Fund. |
| Watch Porter's full breakdown of Project Prophet and Emmet's system |
|
Retail/Wholesale |
|
The discount retail space weathered a relentless storm over the past two years. Soaring inflation forced low-income consumers to ruthlessly prioritize essentials, while retail shrinkage and elevated logistics costs steadily eroded operating margins. Many operators in this space found themselves tra... Read the Full Story |
|
Retail/Wholesale |
|
Levi’s (NYSE: LEVI) turnaround story is one that could be written about in books. The company, an endearing, entrenched, iconic legacy brand, has embraced the modern era, delved deeply into technological advancement, and is now experiencing a virtuous cycle tied to AI. Indeed, Levi’s is now a reta... Read the Full Story |
|
From Our Partners |
|
One company grew Q1 revenue 49% year over year with a 43% gross margin and zero debt. Another holds a $22.7 billion backlog, $2 billion in cash, and more than doubled adjusted EBITDA to $78 million. A semiconductor-test leader saw revenue climb from $686M to $1.282B while analysts model 82.9% EPS growth for 2026.
A free report names all seven companies, breaks down each balance sheet and growth profile, and flags which are expensive, which charts look broken, and where execution risk sits. |
| Click here to get your free copy of this report today |
|
Consumer Staples |
|
Constellation Brands (NYSE: STZ) delivered its fiscal year 2027 Q1 report on June 30 with mixed results. Revenue of $2.43 billion beat expectations for $2.39 billion. However, Constellation missed the bottom line, reporting adjusted earnings per share (EPS) of $3.43, below expectations of $3.70. Ho... Read the Full Story |
|
Aerospace |
|
Global rearmament cycles are actively reshaping the physical economy. Investors are witnessing a rapid transition in which government defense budgets shift from discretionary spending debates to mandatory restocking mandates. When sovereign nations realize their munitions and aircraft are depleted,... Read the Full Story |
|
From Our Partners |
|
Hedge funds are rotating out of AI hype and into the hardware layer powering it. New research identifies three profitable U.S. infrastructure companies leading this shift.
One just posted 76% year-over-year data-center growth. Another holds a $12 billion backlog from global hyperscalers. A third is generating 59%+ gross margins on next-gen chips. |
| Access the full analysis, price setups, and catalysts now |
|
Services |
|
The highly anticipated integration of SpaceX (NASDAQ: SPCX) into the Nasdaq 100 initially looked like a victory lap for early investors and a golden entry point for the retail market. The mechanics of index inclusion often create a powerful short-term liquidity event. When a company joins a major ... Read the Full Story |
|
Business Services |
|
A consortium of Tier 1 U.S. lenders is exploring a $15 billion acquisition of the STAR debit network to bypass federal fee caps and circumvent legacy interchange fees. As traditional credit networks face compounding headwinds from capped merchant settlements and the adoption of decentralized paymen... Read the Full Story |
|
Transportation |
|
Two recent incidents regarding a Boeing 737 MAX aircraft have put Boeing Co. (NYSE: BA) stock back in the spotlight, and not in a good way. Both incidents occurred on Southwest Airlines (NYSE: LUV) jets. The timing is notable, landing just as Boeing works to reassure investors that its production a... Read the Full Story |
|
Technology |
|
The architectural landscape of cloud infrastructure is fracturing. For years, the market assumed legacy hyperscalers like Amazon (NASDAQ: AMZN) and Microsoft (NASDAQ: MSFT) would control the enterprise server space indefinitely, leaving smaller infrastructure providers to fight over budget-consciou... Read the Full Story |
|
Auto/Tires/Trucks |
|
Rivian Automotive Inc. (NASDAQ: RIVN) likely hoped to complete its recent offering of 75 million Class A shares with as little fanfare as possible, but the market had other plans. RIVN shares saw a sharp negative reaction in the days following the company's initial July 6 announcement, a signal th... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision cat... |
Should I Buy Johnson & Johnson Stock? JNJ Bull and Bear Case ExplainedThese insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Johnson & Johnson was last updated on Thursday, July 09, 2026 at 6:06 PM. Johnson & Johnson Bull Case
- The stock has received multiple "buy" ratings from reputable analysts, indicating strong confidence in its future performance.
- Recent price targets from analysts suggest a potential upside, with estimates ranging from $263.00 to $275.00, which could lead to significant returns for investors.
- The current stock price is around $241, which may present a buying opportunity for investors looking for value in a well-established company.
- Johnson & Johnson has a diverse product portfolio across pharmaceuticals, medical devices, and consumer health, which can help mitigate risks associated with market fluctuations.
- With a consensus rating of "Moderate Buy," the overall sentiment among analysts is positive, suggesting that the stock is likely to perform well in the near future.
Johnson & Johnson Bear Case
- Insider selling activity, such as the recent sale of 10,000 shares by an executive vice president, may raise concerns about the company's future prospects.
- Despite positive ratings, the stock has seen fluctuations, and the current price may not reflect its long-term growth potential.
- Corporate insiders own only a small percentage (0.16%) of the company's stock, which could indicate a lack of confidence in the company's future performance.
- Market conditions can be unpredictable, and external factors such as regulatory changes or economic downturns could negatively impact Johnson & Johnson's performance.
- While the company has a strong reputation, competition in the healthcare sector is fierce, and new entrants could challenge its market position.
|
| View Today's Stock Pick |
|
|
|
Post a Comment
0Comments